EP
IDXX icon

Evelyn Partners’s Idexx Laboratories IDXX Stock Holding History

Evelyn Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.9K Buy
+91
New +$51K ﹤0.01% 377

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Evelyn Partners's IDXX Position: Q2 2026 in Review

Evelyn Partners opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 91 shares worth $47.9K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings.

1,231 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Evelyn Partners held 91 shares of Idexx Laboratories worth $47.9K as of Q2 2026.
  • Idexx Laboratories was a new Evelyn Partners position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #377 holding.
  • 1,231 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.